For the coming season, BMW Motorrad is once again offering numerous innovations and innovative solutions with the 2026 ...
Ideaya Biosciences (IDYA) announced it has completed its targeted full enrollment of 435 patients in the registration-enabling Phase 2/3 trial ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced it has completed its ...